ResearcherNorthwestern UniversityActive in the last 2 years
Su Hu
Matched on ORCID iD 0000-0002-3594-0946; OpenAlex author ID A5029974545. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2020: 3 papers · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 2 papers
Papers 5
- Magnetic resonance imaging radiomics-based machine learning model for preoperative prediction of pathological grade in pancreatic cancer: A preliminary study. Last author DOI 10.1016/j.ejro.2025.100703↗
- Preoperative prediction for early recurrence in patients with pancreatic ductal adenocarcinoma: combining radiomics and abdominal fat analysis. Co-author DOI 10.1186/s12880-025-01773-3↗
- Prophylactic dendritic cell vaccination controls pancreatic cancer growth in a mouse model. Co-author DOI 10.1016/j.jcyt.2019.12.001↗
- MRI radiomics for early prediction of response to vaccine therapy in a transgenic mouse model of pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12967-020-02246-7↗
- Dinaciclib prolongs survival in the LSL-Kras G12D/+ ; LSL-Trp53R172H/+ ; Pdx-1-Cre (KPC) transgenic murine models of pancreatic ductal adenocarcinoma. First author PMID 32269732↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Vahid Yaghmai · 3 shared papers, 2020 · strength 0.32
- Paper Dinaciclib prolongs survival in the LSL-Kras G12D/+ ; LSL-Trp53R172H/+ ; Pdx-1-Cre (KPC) transgenic murine models of pa… PMID 32269732↗
- Paper MRI radiomics for early prediction of response to vaccine therapy in a transgenic mouse model of pancreatic ductal aden… DOI 10.1186/s12967-020-02246-7↗
- Paper Prophylactic dendritic cell vaccination controls pancreatic cancer growth in a mouse model. DOI 10.1016/j.jcyt.2019.12.001↗
- Jia Ying Yang · 3 shared papers, 2020 · strength 0.32
- Paper Dinaciclib prolongs survival in the LSL-Kras G12D/+ ; LSL-Trp53R172H/+ ; Pdx-1-Cre (KPC) transgenic murine models of pa… PMID 32269732↗
- Paper MRI radiomics for early prediction of response to vaccine therapy in a transgenic mouse model of pancreatic ductal aden… DOI 10.1186/s12967-020-02246-7↗
- Paper Prophylactic dendritic cell vaccination controls pancreatic cancer growth in a mouse model. DOI 10.1016/j.jcyt.2019.12.001↗
- Aydın Eresen · 3 shared papers, 2020 · strength 0.32
- Paper Dinaciclib prolongs survival in the LSL-Kras G12D/+ ; LSL-Trp53R172H/+ ; Pdx-1-Cre (KPC) transgenic murine models of pa… PMID 32269732↗
- Paper MRI radiomics for early prediction of response to vaccine therapy in a transgenic mouse model of pancreatic ductal aden… DOI 10.1186/s12967-020-02246-7↗
- Paper Prophylactic dendritic cell vaccination controls pancreatic cancer growth in a mouse model. DOI 10.1016/j.jcyt.2019.12.001↗
- Zhuoli Zhang · 3 shared papers, 2020 · strength 0.32
- Paper Dinaciclib prolongs survival in the LSL-Kras G12D/+ ; LSL-Trp53R172H/+ ; Pdx-1-Cre (KPC) transgenic murine models of pa… PMID 32269732↗
- Paper MRI radiomics for early prediction of response to vaccine therapy in a transgenic mouse model of pancreatic ductal aden… DOI 10.1186/s12967-020-02246-7↗
- Paper Prophylactic dendritic cell vaccination controls pancreatic cancer growth in a mouse model. DOI 10.1016/j.jcyt.2019.12.001↗
- Chunhong Hu · 1 shared paper, 2025 · strength 0.30
- Jiayi Bao · 1 shared paper, 2025 · strength 0.30
- Suo Yu Yan · 1 shared paper, 2025 · strength 0.25
- Yun Yan Su · 1 shared paper, 2025 · strength 0.25
- Al B. Benson · 2 shared papers, 2020 · strength 0.22
- Paper Dinaciclib prolongs survival in the LSL-Kras G12D/+ ; LSL-Trp53R172H/+ ; Pdx-1-Cre (KPC) transgenic murine models of pa… PMID 32269732↗
- Paper MRI radiomics for early prediction of response to vaccine therapy in a transgenic mouse model of pancreatic ductal aden… DOI 10.1186/s12967-020-02246-7↗
- Anna Junjie Shangguan · 1 shared paper, 2020 · strength 0.10
- Liang Pan · 1 shared paper, 2020 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.